Table 3.
Society | US evaluation |
---|---|
Six Italian Societies (2018) | Every 6 months in the first 2 years and once a year thereafter |
ESMO (2019) | Every 6–12 months |
JAES (2020) | Once or twice a year |
JAES (2021) | Every 6 months in the first 1–2 years and one a year thereafter |
SFE/AFCE/SFNM (2022) | Every 6 months in the first year and once a year until the end of the 5th year, then at 7 years, then every 2–3 years (level of evidence ++, Grade B) |
Polish Scientific Societies (2022) | Every 6 months in the first 2 years and once a year thereafter (low quality of evidence, weak recommendation) |
SBEM (2022) | Every 6 months in the first 2 years and once a year thereafter |
US, ultrasonography; ESMO, European Society for Medical Oncology; JAES, Japanese Association of Endocrine Surgeons; SFE, French Society of Endocrinology; AFCE, French Association of Endocrine Surgery; SFNM, French Society of Nuclear Medicine; SBEM, Brazilian Society of Endocrinology and Metabolism.